omicsempower

Shanghai OE Biotech Co., Ltd. was founded in 2009 in Shanghai, China, a leading CRO company in the Chinese market. OE Biotech provides multi-omics technology services to a wide range of top universities, hospitals, research institutions and technology-based companies, accelerating the research process of each organization and unit, and using biotechnology to achieve the success of others and benefit the public.The company has built a complete multi-omics testing service platform and a multi-omics big data analysis platform, providing genome, transcriptome, epigenome, microbiome, proteome, metabolome and other whole-omics testing services; and continues to follow the progress of Omics technology. In recent years, the company has gradually developed a comprehensive advantage in single-cell sequencing technology, spatial multi-omics technology, multi-omics joint analysis, etc., and the revenue of such innovative business ranks first in the Chinese market. The company has nearly 600 employees, most of whom have bachelor's degree or above, and nearly half of them have master's degree or doctor's degree.https://www.omicsempower.com/

Yeast Library Platform for Protein & DNA Interaction Discovery

Yeast Library Platform for Protein & DNA Interaction Discovery

Yeast hybrid technology offers a powerful and scalable approach to uncover protein–protein and protein–DNA interactions in a eukaryotic context. At Omics Empower, we provide end-to-end yeast library services—from high-quality cDNA expression library construction to curated transcription factor family screening.

 

Types of Yeast Deletion Library, Yeast Knockout Library Service

Yeast Library Construction

Custom nuclear or membrane cDNA libraries using Gateway® or Smart™ cloning. Optimized for high-complexity Y1H and Y2H applications.

 

Yeast One-Hybrid Screening

Detect transcription factors that bind to your promoter or enhancer regions using DNA–protein interaction assays in yeast.

 

Yeast Two-Hybrid Screening

Identify novel protein–protein interactions using nuclear or membrane-based yeast hybrid systems (mating or co-transformation).

 

Yeast Family Library Screening

Screen your gene of interest against curated TF family libraries from Oryza sativa and Arabidopsis thaliana. Matrix-based, high-throughput format.

 

Reliable Yeast Library Services Trusted by Top Research Institutes

Why Choose Omics Empower?

Proven Expertise

Over 10 years of experience in yeast hybrid systems

 

Published collaborations in Science, Nature, and more

 

High-Quality, Ready-to-Screen Libraries

12-step quality control across the workflow

 

Ready-to-use library vectors and yeast strains included

 

Full Support from Start to Discovery

End-to-end project guidance and fast technical support

 

From sample prep to bioinformatics insights

 

Simplify Your Workflow

 

Ready to explore yeast hybrid screening?

 

Tell us about your sample type or research goals—our team will recommend the best-fit library construction and screening service.

 

Send Your Samples

Submit your samples following our clear guidelines.

 

With labs across Europe, the U.S., and Asia, We support international delivery and offer assistance with nuclear, membrane, or expression library prep.

 

Get Confident Result

Receive QC-verified screening data, along with positive clones, vectors, and follow-up support to move your research forward.

 

Supporting Global Research

With lab operations in the U.S., Europe, and Asia, we provide responsive support for  international projects and multi-site studies. Coordinated logistics ensure timely delivery and sample stability—no matter where your research takes place.

 

If you want to know more about yeast stress response and yeast metabolic engineering, please visit our website.

 

We are a global genetic testing sequencing service provider specializing in multi-omics solutions for life science research. With a strong foundation, we have supported 2,800+ research institutions and tens of thousands of clients, contributing to 5,000+ publications with a cumulative Impact Factor nearing 40,000.

 

 

書き込み

最新を表示する